These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20825363)

  • 1. Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms.
    Ahboucha S
    Curr Mol Pharmacol; 2011 Jan; 4(1):1-13. PubMed ID: 20825363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurosteroid system: implication in the pathophysiology of hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Neurochem Int; 2008; 52(4-5):575-87. PubMed ID: 17610999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2007 Dec; 22(3-4):291-308. PubMed ID: 17823858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.
    Butterworth RF
    J Steroid Biochem Mol Biol; 2016 Jun; 160():94-7. PubMed ID: 26589093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy.
    Jones EA
    Metab Brain Dis; 2002 Dec; 17(4):275-81. PubMed ID: 12602504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of hepatic encephalopathy: update on molecular mechanisms.
    Butterworth RF
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S11-6. PubMed ID: 15025246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GABAergic neurosteroids: the "endogenous benzodiazepines" of acute liver failure.
    Ahboucha S; Gamrani H; Baker G
    Neurochem Int; 2012 Jun; 60(7):707-14. PubMed ID: 22041164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAergic transmission in hepatic encephalopathy.
    Sergeeva OA
    Arch Biochem Biophys; 2013 Aug; 536(2):122-30. PubMed ID: 23624382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint.
    Ahboucha S; Butterworth RF
    Metab Brain Dis; 2004 Dec; 19(3-4):331-43. PubMed ID: 15554425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current theories on the pathogenesis of hepatic encephalopathy.
    Mousseau DD; Butterworth RF
    Proc Soc Exp Biol Med; 1994 Sep; 206(4):329-44. PubMed ID: 7915420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome.
    Albrecht J; Jones EA
    J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.
    Butterworth RF
    Metab Brain Dis; 2001 Jun; 16(1-2):55-65. PubMed ID: 11726089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic encephalopathy: An update of pathophysiologic mechanisms.
    Hazell AS; Butterworth RF
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):99-112. PubMed ID: 10564534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis.
    Ahboucha S; Jiang W; Chatauret N; Mamer O; Baker GB; Butterworth RF
    Neurogastroenterol Motil; 2008 Aug; 20(8):949-57. PubMed ID: 18482252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astroglial dysfunction in hepatic encephalopathy.
    Norenberg MD
    Metab Brain Dis; 1998 Dec; 13(4):319-35. PubMed ID: 10206824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Wiad Lek; 2003; 56(11-12):560-3. PubMed ID: 15058165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurosteroids: biosynthesis and function of these novel neuromodulators.
    Compagnone NA; Mellon SH
    Front Neuroendocrinol; 2000 Jan; 21(1):1-56. PubMed ID: 10662535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "peripheral-type" benzodiazepine (omega 3) receptor in hyperammonemic disorders.
    Desjardins P; Butterworth RF
    Neurochem Int; 2002; 41(2-3):109-14. PubMed ID: 12020611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic encephalopathy: from pathophysiology to treatment.
    Mas A
    Digestion; 2006; 73 Suppl 1():86-93. PubMed ID: 16498256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.